Annual Total Liabilities
$3.53 M
-$818.40 K-18.83%
December 1, 2023
Summary
- As of February 7, 2025, RNAZ annual total liabilities is $3.53 million, with the most recent change of -$818.40 thousand (-18.83%) on December 1, 2023.
- During the last 3 years, RNAZ annual total liabilities has fallen by -$934.70 thousand (-20.94%).
- RNAZ annual total liabilities is now -20.94% below its all-time high of $4.46 million, reached on December 31, 2020.
Performance
RNAZ Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$2.28 M
-$1.22 M-34.79%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ quarterly total liabilities is $2.28 million, with the most recent change of -$1.22 million (-34.79%) on September 1, 2024.
- Over the past year, RNAZ quarterly total liabilities has dropped by -$3.50 million (-60.54%).
- RNAZ quarterly total liabilities is now -74.29% below its all-time high of $8.88 million, reached on March 31, 2021.
Performance
RNAZ Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RNAZ Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.8% | -60.5% |
| 3 y3 years | -20.9% | +3.6% |
| 5 y5 years | +168.5% | - |
RNAZ Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.8% | +39.3% | -60.8% | +32.2% |
| 5 y | 5-year | -20.9% | +168.5% | -74.3% | +32.2% |
| alltime | all time | -20.9% | +168.5% | -74.3% | +32.2% |
TransCode Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.28 M(-34.8%) |
| Jun 2024 | - | $3.50 M(+29.4%) |
| Mar 2024 | - | $2.71 M(-23.3%) |
| Dec 2023 | $3.53 M(-18.8%) | $3.53 M(-39.0%) |
| Sep 2023 | - | $5.79 M(+52.8%) |
| Jun 2023 | - | $3.79 M(-35.0%) |
| Mar 2023 | - | $5.83 M(+34.0%) |
| Dec 2022 | $4.35 M | $4.35 M(+15.3%) |
| Sep 2022 | - | $3.77 M(+118.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $1.73 M(-6.6%) |
| Mar 2022 | - | $1.85 M(-27.0%) |
| Dec 2021 | $2.53 M(-43.2%) | $2.53 M(+14.9%) |
| Sep 2021 | - | $2.20 M(-66.4%) |
| Jun 2021 | - | $6.56 M(-26.2%) |
| Mar 2021 | - | $8.88 M(+99.0%) |
| Dec 2020 | $4.46 M(+239.6%) | - |
| Dec 2020 | - | $4.46 M |
| Dec 2019 | $1.31 M | - |
FAQ
- What is TransCode Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for TransCode Therapeutics?
- What is TransCode Therapeutics annual total liabilities year-on-year change?
- What is TransCode Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly total liabilities year-on-year change?
What is TransCode Therapeutics annual total liabilities?
The current annual total liabilities of RNAZ is $3.53 M
What is the all time high annual total liabilities for TransCode Therapeutics?
TransCode Therapeutics all-time high annual total liabilities is $4.46 M
What is TransCode Therapeutics annual total liabilities year-on-year change?
Over the past year, RNAZ annual total liabilities has changed by -$818.40 K (-18.83%)
What is TransCode Therapeutics quarterly total liabilities?
The current quarterly total liabilities of RNAZ is $2.28 M
What is the all time high quarterly total liabilities for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly total liabilities is $8.88 M
What is TransCode Therapeutics quarterly total liabilities year-on-year change?
Over the past year, RNAZ quarterly total liabilities has changed by -$3.50 M (-60.54%)